WNV E-DIII Specific Neutra™ Antibody (V3S-1123-CJ25), Human IgG (CAT#: V3S-1123-CJ25)

Send Inquiry
  • fig1

Datasheet

MSDS

COA

Summary
Property
Applications
Protocols
Target

Summary

Description This human anti-WNV E DIII neutrilzing antibody (clone pComb3-H-1) recognizes the E protein domain III of West Nile virus (WNV). This antibody, with high binding activities, has been evaluated the neutralizing activities in vitro.
Clonality Monoclonal
Host Species Human
Target Species West Nile virus (WNV)
Isotype Human IgG

Property

Expression Species HEK293F or CHO
Conjugation None
Purity >95%, determined by SDS-PAGE and SEC-HPLC
Endotoxin <1 EU/mg
Purification Protein A affinity purified
Sterility 0.2 μM filtered
Formulation PBS, pH 7.4
Preservation No preservatives
Stabilizer No stabilizers
Storage Store at 4°C within a week. For longer storage, aliquot and store at -20°C.

Applications

Application ELISA; WB; IF; Neut
Application Notes The specific binding activities of this antibody with WNV protein domain III were detected by ELISA, Western Blot and Immunofluorescence assay.

Protocols

ELISA Enzyme-Linked Immunosorbent Assay Protocol
WB Western Blot Protocol
FC Flow Cytometry Protocol

Target

Target WNV E-DIII
Alternative Name Envelope protein; ED3; WNV; West Nile Virus envelope protein domain III
Research Area Microbiology; Infectious Disease
Related Disease Meningitis; Encephalitis
For research use only, not directly for clinical use.
banner banner
© 2025 Creative Biolabs. All Rights Reserved.
antibody
ISO 9001 Certified - Creative Biolabs Quality Management System.
Online Inquiry